Transcatheter vs. Surgical Treatment of Degenerative Mitral Regurgitation

Part of paid clinical trials in Los Angeles, California.

Sponsor
Cedars-Sinai Medical Center
Study ID
NCT07605715
Status
Recruiting

Conditions

  • Degenerative Mitral Valve Disease

Eligibility Criteria

Sex
ALL
Age
60 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to compare the outcomes of transcatheter edge-to-edge repair (TEER) versus surgical mitral valve repair for degenerative mitral regurgitation (DMR) over the long term. The study aims to: 1. Evaluate the effectiveness and safety of TEER versus surgery in patients with DMR over long term. 2. Investigate the predictors of left ventricular dysfunction and clinical outcomes using advanced imaging techniques, such as cardiac MRI 3. Assess patient-reported recovery and quality of life outcomes using validated tools. The study focuses on improving care strategies for patients with DMR, particularly those at higher surgical risk, by identifying optimal treatment approaches and predictors of recovery.

Key Dates

Start date
Feb 19, 2025
Status verified
May 2026
Primary completion
Aug 31, 2027
Completion
Aug 31, 2027

Study Design

Enrollment
60 participants (estimated)

Arms

  • Arm: Surgical mitral repair
    This cohort includes patients who underwent surgical mitral valve repair for severe degenerative mitral regurgitation (DMR). The intervention involves standard surgical techniques to repair the mitral valve, aiming to restore its physiological function and reduce mitral regurgitation.
  • Arm: Transcatheter mitral edge-to-edge repair
    This cohort includes patients who underwent transcatheter edge-to-edge repair (TEER) for severe degenerative mitral regurgitation (DMR). The intervention involves a minimally invasive transcatheter procedure using a device to approximate the mitral valve leaflets, reducing regurgitation.

Primary Outcome Measure

Composite of all-cause mortality, heart failure hospitalization, and valve re-intervention [ Time Frame: From procedure to 3 years after procedure ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Smidt Heart Institute, Cedars Sinai Medical CenterLos AngelesCalifornia90048
Aakriti Gupta, M.D.
267-442-8776

Find similar trials in Los Angeles, CA